This study focuses on patients with ANCA-associated vasculitis, a condition where the body’s immune system attacks its own blood vessels, and rapid-progressive glomerulonephritis, which affects kidney function. The study uses prednisolone, a corticosteroid medication that helps reduce inflammation and suppress the immune system response.
The purpose of this research is to determine if taking corticosteroid medication twice per day, instead of once daily, leads to better control of blood sugar levels. During the study, participants will receive Aprednislon tablets and will wear a special device that continuously monitors their blood sugar levels. The total treatment period lasts 14 days.
The study will track how long blood sugar levels stay within a healthy range throughout the day. Additional measurements will include various blood tests to monitor the effectiveness of treatment and its impact on overall health. Participants will also complete questionnaires about their quality of life during the study period.



Austria